Literature DB >> 4412951

Editorial: Haemoperfusion for jaundice.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4412951      PMCID： PMC1611229     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  10 in total

1.  Congenital jaundice in rats, due to a defect in glucuronide formation.

Authors:  R SCHMID; J AXELROD; L HAMMAKER; R L SWARM
Journal:  J Clin Invest       Date:  1958-08       Impact factor: 14.808

2.  Extracorporeal cation-exchange circuits in the treatment of hyperammonaemia of hepatic failure.

Authors:  J S Juggi
Journal:  Med J Aust       Date:  1973-05-12       Impact factor: 7.738

3.  Toward an artificial liver. II. Removal of cholephilic anions from dogs with biliary obstruction, by hemoperfusion through charged and uncharged resins.

Authors:  R A Willson; A F Hofmann; G G Kuster
Journal:  Gastroenterology       Date:  1974-01       Impact factor: 22.682

4.  Toward an artificial liver: in vitro removal of unbound and protein-bound plasma compounds related to hepatic failure.

Authors:  R A Willson; K H Webster; A F Hofmann; W H Summerskill
Journal:  Gastroenterology       Date:  1972-06       Impact factor: 22.682

5.  Enzymes bound to artificial matrixes.

Authors:  K Mosbach
Journal:  Sci Am       Date:  1971-03       Impact factor: 2.142

6.  Diffusion transport mechanisms in synthetic polymer membranes for haemodialysis.

Authors:  W M Muir; J M Courtney; R A Gray
Journal:  Med Biol Eng       Date:  1970-09

7.  Sepcific removal of in vivo antibody by extracorporeal circulation over an immunoadsorbent in gel.

Authors:  I Schenkein; J C Bystryn; J W Uhr
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

8.  Studies of bilirubin kinetics in normal adults.

Authors:  P D Berk; R B Howe; J R Bloomer; N I Berlin
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

9.  Removing substances from blood by affinity chromatography. I. Removing bilirubin and other albumin-bound substances from plasma and blood with albumin-conjugated agarose beads.

Authors:  P H Plotz; P D Berk; B F Scharschmidt; J K Gordon; J Vergalla
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

10.  Quantitative studies of the delivery of hepatic-synthesized bilirubin to plasma utilizing -aminolevulinic acid-4- 14 C and bilirubin- 3 H in man.

Authors:  E A Jones; R Shrager; J R Bloomer; P D Berk; R B Howe; N I Berlin
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.